HT

Hemant Tukaram Mote

Active Director Designated Partner DIN 11125734
DIN 11125734 First appointment Jun 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Hemant Tukaram Mote

Data last updated:

Hemant Tukaram Mote is a Designated Partner at Shri Siddhivinayak Clinical And Research Center Llp (since 2025).

DIN 11125734
Primary Designation Designated Partner
First Appointment 11 Jun 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner11 Jun 2025Active

Board colleagues of Hemant Tukaram Mote

Directorship timeline

Open interactive timeline →
Shri Siddhivinayak Clinical And Research Center Llp
Premium access

Shareholding and investment profile for Hemant Tukaram Mote

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hemant Tukaram Mote

Hemant Tukaram Mote currently holds 1 directorship: Shri Siddhivinayak Clinical And Research Center Llp (Designated Partner, since 11 Jun 2025).

Hemant Tukaram Mote was first appointed on 11 Jun 2025 as Designated Partner at Shri Siddhivinayak Clinical And Research Center Llp.

The current boards of Hemant Tukaram Mote's companies include Archana Ganesh Yamgar (Shri Siddhivinayak Clinical And Research Center Llp), Ganesh Tatoba Yamgar (Shri Siddhivinayak Clinical And Research Center Llp), Vidya Sachin Mote (Shri Siddhivinayak Clinical And Research Center Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available